Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility

This study has been completed.
Sponsor:
Collaborators:
Janssen, LP
Research Foundation for Mental Hygiene, Inc.
Information provided by:
Nathan Kline Institute for Psychiatric Research
ClinicalTrials.gov Identifier:
NCT00308360
First received: March 28, 2006
Last updated: NA
Last verified: March 2006
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2004
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):